ARTICLE | Company News
First Genetic Trust, GSK pharmacogenetics deal
October 10, 2001 7:00 AM UTC
First Genetic Trust (Chicago, Ill.) and GlaxoSmithKline (GSK; LSE:GSK) will study genetic variations associated with serious drug-related adverse reactions. GSK will sponsor the study and conduct all ...